<?xml version="1.0" encoding="UTF-8"?>
<ref id="B190">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Siveen</surname>
    <given-names>K. S.</given-names>
   </name>
   <name>
    <surname>Mustafa</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Kannaiyan</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ahn</surname>
    <given-names>K. S.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>A. P.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2014</year>). 
  <article-title>Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-kappaB regulated gene products in multiple myeloma xenograft mouse model</article-title>. 
  <source>Oncotarget</source>
  <volume>5</volume>, 
  <fpage>634</fpage>â€“
  <lpage>648</lpage>. 
  <pub-id pub-id-type="doi">10.18632/oncotarget.1596</pub-id>
  <pub-id pub-id-type="pmid">24504138</pub-id>
 </mixed-citation>
</ref>
